[1]
ShresthaS. B., BhusalM., JwarchanJ., GautamS., and ShresthaP. R., “Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients”, J Nepal Health Res Counc, vol. 20, no. 4, pp. 881-885, Jul. 2023.